ConductScience.org, home

Paper20207771

National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancers.

Sturgeon CM and 17 others. Clin Chem, 2010. Cited by 152 papers, by iCite.

Cite this record

ConductScience Library. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancers. Papers, record 20207771. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20207771

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancers.
PubMed
Journal
Clin Chem
PubMed
Year
2010
PubMed
Publication types
Journal Article, Practice Guideline, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
152
iCite
Relative citation ratio, by iCite
4.31
iCite
Revised in PubMed
2026-01-21
PubMed

Authors18

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sturgeon CMCatharine M
2Duffy MJMichael J
3Hofmann BRBarry R
4Lamerz RRolf
5Fritsche HAHerbert A
6Gaarenstroom KKatja
7Bonfrer JJohannes
8Ecke THThorsten H
9Grossman HBH Barton
10Hayes PPeter
11Hoffmann RTRalf-Thorsten
12Lerner SPSeth P
13Löhe FFlorian
14Louhimo JJohanna
15Sawczuk IIhor
16Taketa KKazuhisa
17Diamandis EPEleftherios P
18National Academy of Clinical BiochemistryGroup

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Biomarkers, TumorMajor topic
Clinical Laboratory TechniquesMajor topic
Liver NeoplasmsMajor topic
Stomach NeoplasmsMajor topic
Urinary Bladder NeoplasmsMajor topic
Uterine Cervical NeoplasmsMajor topic
Female
Humans
alpha-Fetoproteins

Source PubMed

Download CSV of topics

Cited by77

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 152 citations.

PMIDTitleJournalYearIn PapersSource
41634619Prognostic stratification in gastric cancer with peritoneal metastasis: tumor biology and diagnostic modality as a surrogate for disease burden.BMC Cancer2026https://conductscience.org/library/papers/41634619PubMed
41025051Establishment and verification of a nomogram model based on the inflammatory indicators of patients with cervical cancer for predicting the risk of their lymph node metastasis.PeerJ2025https://conductscience.org/library/papers/41025051PubMed
40723883The Future of Tumor Markers: Advancing Early Malignancy Detection Through Omics Technologies, Continuous Monitoring, and Personalized Reference Intervals.Biomolecules2025https://conductscience.org/library/papers/40723883PubMed
38946049Phenotypical and biochemical characterization of murine psoriasiform and fibrotic skin disease models in Stabilin-deficient mice.FEBS Open Bio2024https://conductscience.org/library/papers/38946049PubMed
38898088A plug-and-play, easy-to-manufacture fluidic accessory to significantly enhance the sensitivity of electrochemical immunoassays.Sci Rep2024https://conductscience.org/library/papers/38898088PubMed
37835844Method Comparison and Clinical Performance of Breast Cancer Tumor Markers on Novel Multiplex Immunoassay and Automatized LOCI Technology Platforms.Diagnostics (Basel)2023https://conductscience.org/library/papers/37835844PubMed
37476184A preoperative prediction of lymph node metastasis in early cervical squamous cell cancer with hematologica - based model.J Cancer2023https://conductscience.org/library/papers/37476184PubMed
37430160Prognostic significance of post-preoperative tumor markers increments in patients with non-metastatic gastric cancer.J Cancer Res Clin Oncol2023https://conductscience.org/library/papers/37430160PubMed
37370914Longitudinal Evaluation of AFP and CEA External Proficiency Testing Reveals Need for Method Harmonization.Diagnostics (Basel)2023https://conductscience.org/library/papers/37370914PubMed
36505781Data-independent acquisition mass spectrometry identification of extracellular vesicle biomarkers for gastric adenocarcinoma.Front Oncol2022https://conductscience.org/library/papers/36505781PubMed
36230569Prognostic Role of Molecular and Imaging Biomarkers for Predicting Advanced Hepatocellular Carcinoma Treatment Efficacy.Cancers (Basel)2022https://conductscience.org/library/papers/36230569PubMed
34886853Clinical value of MRI, serum SCCA, and CA125 levels in the diagnosis of lymph node metastasis and para-uterine infiltration in cervical cancer.World J Surg Oncol2021https://conductscience.org/library/papers/34886853PubMed
34727105
Clinical value of serum biomarkers, squamous cell carcinoma antigen and apolipoprotein C-II in follow-up of patients with locally advanced cervical squamous cell carcinoma treated with radiation: A multicenter prospective cohort study.
PLoS One2021https://conductscience.org/library/papers/34727105PubMed
34217251Serum epidermal growth factor-like domain 7 serves as a novel diagnostic marker for early hepatocellular carcinoma.BMC Cancer2021https://conductscience.org/library/papers/34217251PubMed
33833581Histogram Analysis of Diffusion-Weighted Magnetic Resonance Imaging as a Biomarker to Predict Lymph Node Metastasis in T3 Stage Rectal Carcinoma.Cancer Manag Res2021https://conductscience.org/library/papers/33833581PubMed
33780049The potential diagnosis role of TP53 mutation in advanced bladder cancer: A meta-analysis.J Clin Lab Anal2021https://conductscience.org/library/papers/33780049PubMed
33575904Prognostic Value of Combination of Inflammatory and Tumor Markers in Resectable Gastric Cancer.J Gastrointest Surg2021https://conductscience.org/library/papers/33575904PubMed
33356502Evaluation of 2 Commercially Systems for Detection of Serum Squamous Cell Carcinoma Antigen in Pan Squamous Cell Carcinoma.Cancer Control2020https://conductscience.org/library/papers/33356502PubMed
33097814Limited usefulness of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for gastrointestinal and whole-body cancer screening.Sci Rep2020https://conductscience.org/library/papers/33097814PubMed
33061563The Prognostic Value of Inflammation Factors in Hepatocellular Carcinoma Patients with Hepatic Artery Interventional Treatments: A Retrospective Study.Cancer Manag Res2020https://conductscience.org/library/papers/33061563PubMed

See all 77 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
AFP174PubTator's text mininghttps://conductscience.org/library/genes/174

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20207771

GET https://conductscience.org/api/papers/v1/20207771/cited_by?page=2